InvestorsHub Logo
icon url

T Stark

07/03/20 11:38 PM

#90600 RE: ecmoney #90595

HCQ now with the Ford Study? It's been in the market for decades. Not sure what the results actually are though for that study.

Obviously Remdesevir with the major Fed buy up by Gil. Baricitinib appears to be an existing RA product already available.